148 related articles for article (PubMed ID: 17354217)
1. Biotech in Italy.
Biotechnol J; 2007 Mar; 2(3):298-300. PubMed ID: 17354217
[No Abstract] [Full Text] [Related]
2. Biotech booms in China.
Ellis S
Nature; 2018 Jan; 553(7688):S19-S22. PubMed ID: 29345681
[No Abstract] [Full Text] [Related]
3. Best of both worlds.
Smaglik P
Nature; 2003 Dec; 426(6967):706-7. PubMed ID: 14668875
[No Abstract] [Full Text] [Related]
4. Swiss on a roll.
Chipman A
Nature; 2007 Aug; 448(7153):525. PubMed ID: 17671476
[No Abstract] [Full Text] [Related]
5. Thanks for sharing.
Dolgin E
Nat Med; 2013 Dec; 19(12):1556-8. PubMed ID: 24309644
[No Abstract] [Full Text] [Related]
6. On the biotech block.
Ossola A
Nature; 2017 Oct; 550(7676):S168-S171. PubMed ID: 29045361
[No Abstract] [Full Text] [Related]
7. Biotechs hold their own in shifting industry.
Mitchell P
Nat Biotechnol; 2002 Nov; 20(11):1065-6. PubMed ID: 12410238
[No Abstract] [Full Text] [Related]
8. Wrong numbers?
Nat Biotechnol; 2010 Aug; 28(8):761. PubMed ID: 20697382
[No Abstract] [Full Text] [Related]
9. Fertile grounds.
Russo G
Nature; 2009 Oct; 461(7268):1308-9. PubMed ID: 19998548
[No Abstract] [Full Text] [Related]
10. Biotech firms jump on SARS bandwagon.
Basu P
Nat Biotechnol; 2003 Jul; 21(7):720. PubMed ID: 12833076
[No Abstract] [Full Text] [Related]
11. Life sciences: all jazzed up.
Mascarelli A
Nature; 2012 Jun; 486(7403):429-31. PubMed ID: 22730564
[No Abstract] [Full Text] [Related]
12. Pay increases for nonfounder executives at private life sciences companies rebound.
Rychlik B
Nat Biotechnol; 2013 Mar; 31(3):259-61. PubMed ID: 23471072
[No Abstract] [Full Text] [Related]
13. Demise of the life science company begins.
Niiler E
Nat Biotechnol; 2000 Jan; 18(1):14. PubMed ID: 10625374
[No Abstract] [Full Text] [Related]
14. Building a life sciences innovation ecosystem.
Harrison KD; Kadaba NS; Kelly RB; Crawford D
Sci Transl Med; 2012 Oct; 4(157):157fs37. PubMed ID: 23100622
[TBL] [Abstract][Full Text] [Related]
15. Massachusetts: Mass effect.
Savage N
Nature; 2016 Sep; 537(7618):S18-9. PubMed ID: 27580137
[No Abstract] [Full Text] [Related]
16. UK industry consolidation is slow despite big merger.
Mitchell P
Nat Biotechnol; 2003 Mar; 21(3):215. PubMed ID: 12610553
[No Abstract] [Full Text] [Related]
17. Antisoma-Roche deal--a new kind of buyout?
Mitchell P
Nat Biotechnol; 2003 Jan; 21(1):3. PubMed ID: 12511894
[No Abstract] [Full Text] [Related]
18. Life sciences and biotechnology in China.
Chen Z; Wang HG; Wen ZJ; Wang Y
Philos Trans R Soc Lond B Biol Sci; 2007 Jun; 362(1482):947-57. PubMed ID: 17331895
[TBL] [Abstract][Full Text] [Related]
19. Crossing the line.
Blaivas JG
Neurourol Urodyn; 2002; 21(3):185. PubMed ID: 11948709
[No Abstract] [Full Text] [Related]
20. Little biotech on the prairie.
Wolfson W
Chem Biol; 2007 Sep; 14(9):969-71. PubMed ID: 17884626
[No Abstract] [Full Text] [Related]
[Next] [New Search]
